Clinical Trials Directory

Trials / Completed

CompletedNCT01206153

Metformin for Treatment Antipsychotic Induced Amenorrhea in Female Schizophrenic Patients

Metformin for Treatment Antipsychotic Induced Amenorrhea in Female Schizophrenic Patients: a Double Blind, Placebo-controlled Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
84 (actual)
Sponsor
Central South University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

Antipsychotics such as risperidone could induce amenorrhea in schizophrenic patients. The investigators conducted a randomized, placebo-controlled study to test the efficacy of metformin for antipsychotic induced amenorrhea in schizophrenia patients.

Conditions

Interventions

TypeNameDescription
DRUGmetformin

Timeline

Start date
2008-06-01
Primary completion
2010-01-01
Completion
2010-03-01
First posted
2010-09-21
Last updated
2010-09-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01206153. Inclusion in this directory is not an endorsement.

Metformin for Treatment Antipsychotic Induced Amenorrhea in Female Schizophrenic Patients (NCT01206153) · Clinical Trials Directory